Capital Markets / Shareholder Activism
We are one of very few law firms in Israel that has played a role in shareholder activist matters.
Our team has led a number of high-profile local and cross-border challenges of control of Israeli incorporated public companies.
We represent activist investors and investment funds, advising them on a wide variety of activist strategies, including boardroom battles, hostile takeovers, and related court proceedings.
We have a proven track record in identifying opportunities for effecting change for our clients, in unlocking significant shareholder value, and in procuring settlements with these activist investors.
At the same time, we understand the risks and challenges a company faces by having activist directors on its board. Thus, we assist publicly-listed and privately-held corporations in creating strategies for minimizing such risks, as well as prepare them for the possibility of an activist attack. We also provide ongoing advice to companies in defense against potential and current proxy fights or other shareholder activism.
Micky Barnea, who heads the team, has over 30 years of experience in advising on activism defense, takeovers, and corporate governance. An expert in this field, he speaks regularly about shareholder activism at conferences and panels. He is also frequently interviewed and quoted by the local media.
Insights & News - Capital Markets / Shareholder Activism:
Control Struggles in Israeli Public Companies
Micky Barnea analyzes the issue of control struggles, hostile takeover attempts, and directors’ potential defensive measures. His op-ed was published in TheMarker's Ahad Ha'am magazine.
Interview with Micky Barnea: Takeovers of Public Companies
Recent years have seen several takeover attempts of companies listed on the Tel Aviv Stock Exchange. Already in early 2022 was there a control struggle over Norstar Holdings Inc. As an expert lawyer in the field of corporate takeovers, Micky Barnea was interviewed by TheMarker for an article on the subject.
In the interview, Micky explained that “control takeovers begin with a combination of two things: an analysis to identify the business potential and a legal analysis that clarifies which steps are required to acquire control.”
Barnea Representing Knight Therapeutics in Minority Discrimination Lawsuit in Israel
Our firm is representing Knight Therapeutics, a Canadian public company that holds 28% of Israeli pharmaceutical company Medison's shares, in a lawsuit alleging the deprivation of its rights as a minority shareholder in Medison. The company is represented by Advs. Zohar Lande, Eyal Nachshon, and Omer Keydar of our Litigation Department.
Capital Markets / Shareholder Activism
We are one of very few law firms in Israel that has played a role in shareholder activist matters.
Our team has led a number of high-profile local and cross-border challenges of control of Israeli incorporated public companies.
We represent activist investors and investment funds, advising them on a wide variety of activist strategies, including boardroom battles, hostile takeovers, and related court proceedings.
We have a proven track record in identifying opportunities for effecting change for our clients, in unlocking significant shareholder value, and in procuring settlements with these activist investors.
At the same time, we understand the risks and challenges a company faces by having activist directors on its board. Thus, we assist publicly-listed and privately-held corporations in creating strategies for minimizing such risks, as well as prepare them for the possibility of an activist attack. We also provide ongoing advice to companies in defense against potential and current proxy fights or other shareholder activism.
Micky Barnea, who heads the team, has over 30 years of experience in advising on activism defense, takeovers, and corporate governance. An expert in this field, he speaks regularly about shareholder activism at conferences and panels. He is also frequently interviewed and quoted by the local media.
Insights & News - Capital Markets:
Control Struggles in Israeli Public Companies
Micky Barnea analyzes the issue of control struggles, hostile takeover attempts, and directors’ potential defensive measures. His op-ed was published in TheMarker's Ahad Ha'am magazine.
Interview with Micky Barnea: Takeovers of Public Companies
Recent years have seen several takeover attempts of companies listed on the Tel Aviv Stock Exchange. Already in early 2022 was there a control struggle over Norstar Holdings Inc. As an expert lawyer in the field of corporate takeovers, Micky Barnea was interviewed by TheMarker for an article on the subject.
In the interview, Micky explained that “control takeovers begin with a combination of two things: an analysis to identify the business potential and a legal analysis that clarifies which steps are required to acquire control.”
Barnea Representing Knight Therapeutics in Minority Discrimination Lawsuit in Israel
Our firm is representing Knight Therapeutics, a Canadian public company that holds 28% of Israeli pharmaceutical company Medison's shares, in a lawsuit alleging the deprivation of its rights as a minority shareholder in Medison. The company is represented by Advs. Zohar Lande, Eyal Nachshon, and Omer Keydar of our Litigation Department.